On this episode of Stock Movers:
- SoHo House (SHCO) is higher on news it is going private. Soho House & Co Inc. has entered into definitive agreements pursuant to which an investor group led by MCR and its Chairman and CEO Tyler Morse will acquire the outstanding shares of Soho House not held by certain significant shareholders.
- Dayforce (DAY) shares are higher on news Thoma Bravo is in talks to acquire human resources management software provider Dayforce Inc., according to people familiar with the matter. The buyout firm is planning to take the Minneapolis-based company private in a deal that could be announced as soon as the coming weeks, the people said.
- Novo Nordisk (NVO) shares advanced after the drugmaker's weight-loss drug Wegovy received US approval to treat a serious form of liver disease. The US Food and Drug Administration's decision "could start to help shift the momentum for Novo following a more difficult start to the year," according to Evan David Seigerman, an analyst at BMO Capital Markets.
- Tonix Pharmaceuticals (TNXP) shares surged following a trading halt ahead of an announcement that the firm received FDA approval for Tonmya to treat fibromyalgia in adults.

On this episode of Stock Movers: - SoHo House (SHCO) is higher on news it is going private. Soho House &amp; Co Inc. has entered into definitive agreements pursuant to which an investor group led by MCR and its Chairman and CEO Tyler Morse will acquire the outstanding shares of Soho House not held by certain significant shareholders. - Dayforce (DAY) shares are higher on news Thoma Bravo is in talks to acquire human resources management software provider Dayforce Inc., according to people familiar with the matter. The buyout firm is planning to take the Minneapolis-based company private in a deal that could be announced as soon as the coming weeks, the people said. - Novo Nordisk (NVO) shares advanced after the drugmaker's weight-loss drug Wegovy received US approval to treat a serious form of liver disease. The US Food and Drug Administration's decision "could start to help shift the momentum for Novo following a more difficult start to the year," according to Evan David Seigerman, an analyst at BMO Capital Markets. - Tonix Pharmaceuticals (TNXP) shares surged following a trading halt ahead of an announcement that the firm received FDA approval for Tonmya to treat fibromyalgia in adults.

Listen for five-minute conversations on today's biggest winners and losers in the stock market. Subscribe for analysis on the companies making news on Wall Street.

Listen for five-minute conversations on today's biggest winners and losers in the stock market. Subscribe for analysis on the companies making news on Wall Street.

Listen for news on today's biggest winners and losers in the stock market.

Stock Movers

SoHo and Dayforce Private Talks; Novo and Tonix See Pharma Jump

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/b2a460da-2a21-4aae-9704-b33d00b69a22/transcript

Advertisement